{
    "clinical_study": {
        "@rank": "168130", 
        "arm_group": [
            {
                "arm_group_label": "Ultramicronized PEA (Normast)", 
                "arm_group_type": "Experimental", 
                "description": "Normast is ultramicronized Palmitoylethanolamide (PEA) classified as \"Dietary foods for special medical purposes\"."
            }, 
            {
                "arm_group_label": "Microgranules", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Randomized, double-blinded, placebo-controlled, parallel group study of ultramicronized PEA\n      (Normast)600 mg x 2 daily or corresponding placebo with a week of baseline period followed\n      by 1 x 12 weeks treatment period."
        }, 
        "brief_title": "Ultramicronized PEA (Normast) in Spinal Cord Injury Neuropathic Pain", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Neuropathic Pain", 
            "Spinal Cord Injury"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neuralgia", 
                "Spinal Cord Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "Study design: Randomized, double-blinded, placebo-controlled, parallel, multi-center study\n      of ultramicronized PEA (Normast)with a week of baseline period followed by 1 x 12 weeks\n      treatment period.\n\n      Methodology: Given Normast 600mg x 2 daily or corresponding placebo and kept on that dose\n      for 12 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged 18 years or more with at- and/or below-level neuropathic pain for at\n             least 3 months due to trauma or disease of the spinal cord or cauda equina (of at\n             least 6 months old) with a mean pain intensity from 4 to 9 on a 0-10 point numeric\n             rating scale (NRS) during a one-week baseline period will be eligible for the study\n\n        Exclusion Criteria:\n\n          -  known concomitant severe cerebral damage, terminal illness, planned surgery,\n             pregnancy or lactation, alcohol or substance abuse, hypersensitivity to PEA or\n             carrier, and psychiatric disease except depression."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01851499", 
            "org_study_id": "Normast-2013"
        }, 
        "intervention": {
            "arm_group_label": "Ultramicronized PEA (Normast)", 
            "intervention_name": "Ultramicronized PEA (Normast)", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Neuropathic pain following spinal cord injury", 
        "lastchanged_date": "May 9, 2013", 
        "location": [
            {
                "contact": {
                    "email": "fin.biering-soerensen@regionh.dk", 
                    "last_name": "Fin Biering-Soerensen, Professor", 
                    "phone": "+45 3545 1950"
                }, 
                "facility": {
                    "address": {
                        "city": "Hornbaek", 
                        "country": "Denmark", 
                        "zip": "3100"
                    }, 
                    "name": "Department of Spinal Cord Injuries"
                }, 
                "investigator": [
                    {
                        "last_name": "Jette Bing, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Fin Biering-Soerensen, Professor", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sven R. Andresen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Viborg", 
                        "country": "Denmark", 
                        "zip": "8800"
                    }, 
                    "name": "Spinal Cord Injury Centre of Western Denmark"
                }, 
                "investigator": [
                    {
                        "last_name": "Sven R. Andresen, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Inger L. Johannesen, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rikke M. Hansen, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ellen M. Hagen, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ultramicronized PEA (Normast) in Spinal Cord Injury Neuropathic Pain: a Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center Study", 
        "other_outcome": [
            {
                "measure": "Blindness is assessed by asking the patients and treating physician which treatment they believed they recieved and the reason for this", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Adverse events are assessed using open-ended questions both during and after treatment period.\nSAE reporting will be performed according to GCP and regulatory requirements.", 
                "measure": "Number of patients with adverse events and number, type and severity of adverse events.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "overall_contact": {
            "email": "sven.robert.andresen@midt.rm.dk", 
            "last_name": "Sven R. Andresen, MD", 
            "phone": "+45 7844 6156"
        }, 
        "overall_contact_backup": {
            "email": "finnerup@ki.au.dk", 
            "last_name": "Nanna B. Finnerup, MD", 
            "phone": "+45 7846 3455"
        }, 
        "overall_official": {
            "affiliation": "Spinal Cord Injury Centre of Western Denmark", 
            "last_name": "Sven R. Andresen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: The National Committee on Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in mean pain intensity on a 0-10 numerical rating scale from baseline week to last week of treatment", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01851499"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Spasticity/spasms and sleep disturbance, change in mean score from baseline to last week of treatment", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Modified Tardieu and clonus over ankle joints", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Spasticity and spasms on a 0-10 NRS", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Health related quality of life S-TOPS", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Global Impression of Change", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Pain relief of overall pain and at-and below level pain", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "allodynia(touch and cold)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Pain symptoms evaluated by NPSI", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "pain impact on activities, sleep and mood", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "effect on unpleasantness", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "escape medication", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Insomnia Severity Index", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "anxiety(GAD-10)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "depression(MDI)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "NNT for 33% and 50% pain reduction", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Combined spasticity and pain score (CPSS)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Numbers of responders (33% pain reduction) in those with and without allodynia/hyperalgesia and those with different pain symptoms (NPSI)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Danish Pain Research Center", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Spinal Cord Injury Centre of Western Denmark", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Department of Spinal Cord Injuries, Glostrup Hospital, Hornbaek, Denmark", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Epitech Group SRL, Italy", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Danish Pain Research Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}